Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathway

Keyphrases

• Tumor Necrosis Factor-α 100%
• RhoA 100%
• Rho Kinase 100%
• Tumor Tissue 100%
• Virus-like Particles 100%
• Tumor 40%
• Adenovirus 40%
• Inflammatory Cytokines 20%
• Long-circulating 20%
• Therapeutic Agents 20%
• Fold Increase 20%
• Cancer Treatment 20%
• Albumin 20%
• Tumor Cells 20%
• Low Efficiency 20%
• Isolated Limb Perfusion 20%
• Evans Blue 20%
• Tumor Uptake 20%
• Viral Infection 20%
• Endothelial Layer 20%
• Viral Particles 20%
• Permeabilizing Activity 20%
• Oncolytic Virotherapy 20%
• Oncolytic Virus 20%
• Y-27632 20%
• Rho Kinase Inhibitor 20%
• Lytic Virus 20%
• Polymer-coated 20%
• Intravenous Administration 20%
• Permeabilization 20%

Medicine and Dentistry

• Tumor Necrosis Factor 100%
• Neoplasm 100%
• Rho Kinase 100%
• Virus Particle 100%
• Extravasation 100%
• In Vitro 40%
• Adenoviridae 40%
• Inflammatory Cytokine 20%
• Therapeutic Agent 20%
• Cancer Therapy 20%
• Antiinfective Agent 20%
• Limb Perfusion 20%
• Tumor Cell 20%
• Y-27632 20%
• Oncolytic Virus 20%
• Virus Infection 20%
• Evans Blue 20%
• Oncolytic Virotherapy 20%
• Rho Kinase Inhibitor 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Tumor Necrosis Factor 100%
• Neoplasm 100%
• Rho Kinase 100%
• Extravasation 100%
• Adenoviridae 33%
• Cytokine 16%
• Antiinfective Agent 16%
• Malignant Neoplasm 16%
• Limb Perfusion 16%
• Rho Kinase Inhibitor 16%
• Evans Blue 16%
• Virotherapy 16%
• Virus Infection 16%
• Oncolytic Virus 16%